Kalogon
Melbourne, US · Founded 2022 · Delaware corporation · 2 known investors
Kalogon develops advanced seating technologies, including smart cushions, aimed at improving comfort and health for people who must sit for extended periods. The company draws on clinical research and customer feedback to address the health risks and discomfort associated with prolonged sitting.
Founders & leadership
Kalogon was founded in 2022 by Tim Balz, Aaron Jones, and Timothy Balz.
.jpg)
.jpg)


Investors · 2
Reported raises · per SEC filings
Form D private placements$11.8M disclosed across 4 rounds · 2022–2026
▶$5.7MraisedJun 2026 · 22 investors · Other Health CareRule 506(b)
- Tim BalzExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $5.7M
- Minimum investment
- $10K
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$2.9MraisedJun 2026 · 22 investors · Other Health CareRule 506(b)
- Tim BalzExecutive Officer, Director
- Offering amount
- $2.9M
- Amount sold
- $2.9M
- Minimum investment
- $10K
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$1.2MraisedJun 2024 · 17 investors · Other Health CareRule 506(b)
- Arushi RainaDirector
- Timothy BalzExecutive Officer, Director
- Jeff ReadyDirector
- Marcin KubiakDirector
- Mark BergrenDirector
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- Minimum investment
- $10K
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$1.9MraisedAug 2022 · 9 investors · Other Health CareRule 506(b)
- Marcin KubiakDirector
- Tim BalzExecutive Officer, Director
- Mark BergrenDirector
- Jeff ReadyDirector
- Offering amount
- $1.9M
- Amount sold
- $1.9M
- Minimum investment
- $150K
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. Air ForceAir Force | Phase II | 2022 | $1.2M |
| Department of Health and Human ServicesAdministration for Community Living | Phase I | 2022 | $99.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Kalogon has filed a notice of an exempt offering of securities to raise $7 Million in New Funding. - intelligence360intelligence360.news · Jul 2026
Kalogon has raised $5,750,000.00 in new funding - intelligence360intelligence360.news · Jun 2026Frequently asked questions
- What does Kalogon do?
- Kalogon develops advanced seating technologies, including smart cushions, aimed at improving comfort and health for people who must sit for extended periods. The company draws on clinical research and customer feedback to address the health risks and discomfort associated with prolonged sitting.
- Who founded Kalogon?
- Kalogon was founded by Tim Balz, Aaron Jones, Timothy Balz in 2022.
- Who are Kalogon's investors?
- Kalogon's investors include Enable Ventures, DeepWork Capital.
- How much funding has Kalogon raised?
- Kalogon has disclosed $11.8M raised across 4 rounds.
- Where is Kalogon headquartered?
- Kalogon is headquartered in Melbourne, US.